An Urgent Need to Map Biodiversity

The scientific imagination has been stirred by a call for complete sequencing of the human genome (The Scientist, October 20, 1986, pp. 11-12). The prospect is attractive because it offers an Everest-like goal, the entrainment of new advances in high technology, and the promise of practical applications in medicine. A close parallel exists in the mission envisioned by other biologists to describe and characterize the remainder of life on Earth. Where the genome project will search inwardly to ma

Written byEdward Wilson
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

A close parallel exists in the mission envisioned by other biologists to describe and characterize the remainder of life on Earth. Where the genome project will search inwardly to map several billion base-pairs comprising 100,000 to 300,000 genes, the biodiversity project will explore outwardly to encompass the still largely unknown millions of species of animals, plants and microorganisms on which human existence depends.

A recent tabulation places the number of described species at about 1.6 million (a large majority of which are insects and plants). But the actual number believed to exist ranges from four million to more than 30 million. Each species in turn is composed of millions or even billions of base-pairs. Those portions that make a species unique are also very old. The average life of a species—or "clade," a set of closely related species derived from a single ancestral stock—is from one to 10 million years ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies